VIA
OLMA icon

Virtus Investment Advisers’s Olema Pharmaceuticals OLMA Stock Holding History

Virtus Investment Advisers’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$123K Buy
8,250
+201
+2% +$4.47K 0.03% 446
2025
Q4 		$201K Sell
8,049
-19,977
-71% -$355K 0.05% 368
2025
Q3 		$274K Buy
28,026
+4,865
+21% +$29.2K 0.08% 242
2025
Q2 		$98.7K Sell
23,161
-1,266
-5% -$5.64K 0.03% 339
2025
Q1 		$91.8K Buy
+24,427
New +$123K 0.03% 432

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Virtus Investment Advisers's OLMA Position: Q1 2026 in Review

Virtus Investment Advisers increased its Olema Pharmaceuticals (OLMA) stake by 2.5% in Q1 2026, buying an estimated $4.47K and bringing the position to 8,250 shares worth $123K. The position accounts for 0.03% of the portfolio, ranked #446.

Virtus Investment Advisers first reported a position in OLMA in Q1 2025 and has held it in 5 quarters since. The position peaked at $274K in Q3 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Virtus Investment Advisers held 8,250 shares of Olema Pharmaceuticals worth $123K as of Q1 2026.
  • Virtus Investment Advisers bought 201 Olema Pharmaceuticals shares in Q1 2026, an estimated $4.47K.
  • Olema Pharmaceuticals made up 0.03% of Virtus Investment Advisers's portfolio in Q1 2026, its #446 holding.
  • Virtus Investment Advisers first reported a position in Olema Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Virtus Investment Advisers's Olema Pharmaceuticals position peaked at $274K in Q3 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.